🔴 Heron Therapeutics is trading 7.13% down today with no fresh company-specific catalyst identified

Heron Therapeutics is trading at $0.31 (-7.13%) now, with no fresh company-specific catalyst directly explaining the August 17, 2026 decline identified.

• The August 13 amendment extended the Tax Benefit Preservation Plan through August 14, 2029.
• Recent pressure followed the August 10 earnings miss and revenue shortfall.
• Broader markets are lower, but the decline is insufficient to establish a market-wide cause.